SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 37.19% in the sales to Rs. 1604.00 millions was observed for the quarter ended September 2021. The sales figure stood at Rs. 1169.20 millions during the year-ago period.Net profit for the quarter ended September 2021 increased significantly by 57.93% to Rs. 651.60 millions from Rs. 412.60 millions.OP of the company witnessed a marginal growth to 898.20 millions from 594.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1604.00 1169.20 37.19 2879.00 2366.50 21.66 4826.80 5278.30 -8.55
Other Income 184.20 32.40 468.52 377.50 72.90 417.83 186.20 659.70 -71.78
PBIDT 898.20 594.60 51.06 1654.60 1209.60 36.79 2325.50 2729.70 -14.81
Interest 0.20 0.40 -50.00 0.50 0.90 -44.44 1.70 1.80 -5.56
PBDT 898.00 594.20 51.13 1654.10 1208.70 36.85 2323.80 2727.90 -14.81
Depreciation 63.10 54.30 16.21 125.10 108.60 15.19 224.40 196.50 14.20
PBT 834.90 539.90 54.64 1529.00 1100.10 38.99 2099.40 2531.40 -17.07
TAX 183.30 127.30 43.99 331.90 267.30 24.17 537.10 554.90 -3.21
Deferred Tax 2.80 -4.80 -158.33 5.10 -9.60 -153.13 -11.70 -4.00 192.50
PAT 651.60 412.60 57.93 1197.10 832.80 43.74 1562.30 1976.50 -20.96
Equity 151.30 151.30 0.00 151.30 151.30 0.00 151.30 151.30 0.00
PBIDTM(%) 56.00 50.86 10.11 57.47 51.11 12.44 48.18 51.72 -6.84

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×